Euro-Sante :: Euro-Health

Archives for Technologies

Considerable public funding goes into research. To the dismay, though, of many, European countries in the main are very poor at commercialising this research, and thus return of this public investment is often zero euros. Reasons lie in at least two places: EU member states (outside of the ‘anglo’ tradition) tend to ‘own’ their own… » read more

Posted by EuroSante

Greedy governments stifle innovation by reserving all the intellectual property of publicly funded research for their own use. The problem is that governments are not very good at knowing what to do next, and invariably tie up valuable innovation in bureaucratic process, without adding any social value at all. The Eurocrats like US comparisons, so… » read more

Posted by EuroSante

The Innovative Medicines Initiative seeks to put right the chaotic treatment of pharmaceutical innovation by EU member states, and will likely fail. The goose that lays golden eggs of medical innovation is cooked to death by member state medicines policies. Increasing the speed of product development will come to a grinding halt as member states… » read more

Posted by EuroSante